Augmented Reality-based Telerehabilitation Platform for Patients With Stroke

Stanford University

Overview

The study is to 1) determine the feasibility of the use of our augmented reality (AR) rehabilitation program, including its preliminary efficacy, 2) determine the feasibility of obtaining an augmented reality assessment based on the Fugl-Meyer Assessment - Upper Extremity (FMA-UE).

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Conditions

Stroke

Interventions

AR rehabilitation appDEVICE

The intervention will consist of an 8-week home rehabilitation program during which the participant will have 1) a total of 7 weekly remote video visits with a therapist and 2) daily at-home exercises using the AR headset with rehabilitation app, done independently.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. 18 years or older 2. ≥3 months post ischemic or hemorrhagic stroke 3. Upper extremity deficit with an FMA-UE score between 20-50 4. Able to operate the AR device independently or with the help of a caregiver 5. Sufficiently proficient in the English language to follow instructions from Reia Exclusion Criteria: 1. History of developmental, neurological or psychological impairment leading to functional disability 2. Vision or visual field impairment that interferes with the use of the AR headset 3. Severe photosensitivity that makes use of the AR headset uncomfortable 4. History of visually provoked seizures 5. Hearing aids 6. Cardiac pacemaker 7. Implantable cardioverter-defibrillator (ICD)

Locations (1)

Stanford University

Stanford, California, United States

Outcomes

Primary Outcomes

Adherence

Percentage of days during the 8-week intervention period that a patient completes their 30-minute rehabilitation session.

Time frame: 8 weeks

Percentage of participants who successfully complete the vFMA-UE

Feasibility of obtaining the Fugl-Meyer Assessment - Upper Extremity (vFMA-UE) unsupervised, described by the percentage of participants who successfully complete the vFMA-UE at home on day 70, among patients who attempted to do the unsupervised vFMA-UE.

Time frame: Day 70

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.